Ichnos · industry survey
Can you advertise nuclear medicine and industrial isotope transport?
Yes — in 9 places we have confirmed, out of 47examined. Not on the major platforms: couriers and logistics operators moving radioactive isotopes with short half-lives (Technetium-99m, Fluorine-18) between cyclotrons and hospitals face systematic ad bans due to automated filters catching all words relating to nuclear and radioactive materials.
That is a fact about the platform’s category rules, not a finding about any business in it. The audience has not gone anywhere — it simply gathers somewhere the ad platforms do not sell access to. Each of the 9 says so in its own words, on its own page, and we quote the sentence — so the answer is checkable rather than asserted.
- Places found
- Publications, associations, forums and directories where this industry’s own language is actually spoken.
- Confirmed open
- These say in their own words that an outsider may take part. We quote the sentence, so you can judge it rather than take ours.
- You can simply buy
- Advertising, sponsored placement or event presence — a budget and a decision, not an application.
- Worth, per year
- Estimated value of the placement you could buy here. Banded from what each destination offers — not from rate cards we do not hold.
What these places let an outsider do
Almost none of it is guest posting. For an industry that cannot buy ads on the major platforms, an advertising page on a trade publication is not a lesser option — it is the channel.
Why the ordinary channels are closed
Most categories are locked out by one of these. Nuclear medicine and industrial isotope transport carries both.
Gated behind certification
Advertising is technically permitted but only after an approval process — often slow, often expensive, and frequently limited by state or by what may be said once approved. The gate is real rather than nominal: many businesses in the category never clear it, and those that do still cannot say the thing that would make the advertisement work.
Restricted by a regulator, not just a platform
A public body governs what may be claimed, to whom, and with what disclosure. This one does not go away by changing channel — the same rules apply to a trade publication, a conference talk and a mailing. What changes off-platform is that the channel will actually carry the message once it is compliant.
Where to start, and why in this order
Ordered by what you can act on soonest, not by what we found most of. A route that takes a rate card and a date beats one that takes a relationship, when the question is what to do on Monday.
- 1Buy advertising 3 places
3 of the 9 open destinations in nuclear medicine and industrial isotope transport sell placement outright, which makes this the fastest route in the category: there is nothing to negotiate and nobody to persuade, only a rate card and a date. At 3, this is a shortlist rather than a market. Price all of them before committing to any, because there is no second tier to fall back on.
- 2Send a press release 1 place
Free, and worth exactly as much as the news in it. 1 destination publishes announcements from nuclear medicine and industrial isotope transport. A category wire will run a genuine announcement — a licence, a location, a hire — and will ignore a rewritten product page.
- 3Place sponsored content 4 places
Slower and more expensive than a banner, and worth more: it carries the publication's context rather than sitting beside it. 4 destinations in nuclear medicine and industrial isotope transport will take it. Disclosure is mandatory and is not a drawback — an audience that knows what it is reading trusts the publication that told them, which in a category the platforms have already refused is worth more than the impression.
- 4Sponsor or exhibit 1 place
The most expensive route and often the highest intent, because the people in the room chose to be there. Nuclear medicine and industrial isotope transport has 1 destination selling event presence. With only 1, the calendar is small enough that the good slots are spoken for months ahead — ask for next year's prospectus rather than this year's remainder.
- 5Join as a member 1 place
Slowest to pay off and hardest for a competitor to replicate. 1 body accepts members from nuclear medicine and industrial isotope transport, and membership usually unlocks the newsletter, the directory and the event at member rates — so treat each one as the key to three routes rather than as one on its own. In a category the platforms refuse, standing is the asset that cannot be switched off by a policy change.
- 6Contribute an article 1 place
Requires something to say that somebody working in nuclear medicine and industrial isotope transport would not already know. 1 destination accepts contributed articles. Where it works it works well: a contributed piece carries a byline and a link and stays indexed for years, which is the one form of presence here that appreciates.
Start with these — free, no account
3 of the confirmed-open destinations for nuclear medicine and industrial isotope transport accept outside participation without charging for it. No budget, no ad account, no permission from a platform. Open any one and look for the way in.
- Health Physics Society (HPS)hps.orgJoin as a member
“Other activities include projects such as special membership surveys or reviews of the membership application/process.”hps.org, read this year
- Applied Radiology Industry News Deskappliedradiology.comContribute an article
“As a general rule, Applied Radiology follows the manuscript submission guidelines and requirements set forth by the International Committee of Medical Journal Editors (ICMJE).”appliedradiology.com, read this year
- BioSpacebiospace.comSend news
A further 8 destinations sell access outright — advertising, sponsored placement or event presence. Those need a budget and a decision rather than an application, and they come with the rate-card route and the sentence from each destination’s own policy page in the paid map.
Not ready yet
15 more confirmed-open places before this map is worth selling. We will not put a price on one that would send you somewhere thin — ask us to prioritise it and it moves up the queue.
Questions people in this category actually ask
Answered plainly, including the one where the honest answer is “don’t”.
Why was my nuclear medicine and industrial isotope transport ad account banned or rejected?
Almost always for the category rather than for anything specific to your business. The major platforms apply their rules to nuclear medicine and industrial isotope transport as a class, so a licensed, compliant operator is refused on the same footing as one that is not. It is a fact about their category rules, not a finding about you — which is also why appealing rarely works: there is nothing about your individual account to reconsider.
Can I get around it with a second account or a different nuclear medicine and industrial isotope transport business name?
Do not. This is the advice most readily available elsewhere and it is the advice that ends businesses. Platforms link accounts by payment method, device, IP, business registration and staff logins; a second account discovered is usually a permanent termination of everything connected to it, rather than the suspension you started with. It is a particularly bad trade in nuclear medicine and industrial isotope transport, where 9 destinations already publish a way in and 8 of them will take your money today — you would be risking the business to avoid an afternoon's work. The route out of a category ban is a different channel, not a different login.
Where can nuclear medicine and industrial isotope transport advertise instead?
Where the industry already gathers. We have mapped 47 such places — trade publications, associations, professional forums and directories — and 9 of them publish a way in for outside businesses, read off their own pages and quoted. 8 of those sell advertising, sponsored placement or event presence outright, which means a budget and a decision rather than an application.
Is this just a list of nuclear medicine and industrial isotope transport websites?
No, and the difference is the whole product. A list of places your audience gathers is a reading list. What makes it a map is the permission column: for each place, whether it publishes a way in, what kind, and the sentence on their own site that says so. We read 47 destinations serving nuclear medicine and industrial isotope transport to find the 9 that say yes — and the 38 that say nothing either way are the reason a list is not enough. Anyone can assemble the list; the reading is the work.
Industries in the same position
Shut out the same way nuclear medicine and industrial isotope transport is — same kind of refusal, so the same shape of answer.
How this was assembled
Learn the language
The vocabulary this industry uses among itself — its regulators, licences, statutes and trade bodies. Say them correctly and you are inside the trade.
Find where it is spoken
The publications, associations and forums where that vocabulary actually appears. Not where an audience might be — where its language demonstrably is.
Check the way in
Whether each place accepts anything from outside, read from its own advertising or submissions page and quoted verbatim.